Amazon coin set to soar 25X – starting December 16th?

This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team of crypto experts has identified it as the most promising crypto of 2024. You can see all of the details surrounding the #1 Crypto of 2024

David Demski Biography and Net Worth

CEO of Globus Medical

David Demski has been Globus Medical’s President and Chief Executive Officer since August 2017. He previously served as our Chief Financial Officer from 2003 to July 2008 and as the President, Emerging Technologies. Prior to joining Globus Mr. Demski founded Cornerstone Capital LBO Fund, a boutique leveraged buyout consultancy. Mr. Demski’s experience also includes serving as Vice President for Gilo Ventures, a Silicon Valley-based venture capital fund, and serving as Chief Operating Officer of Rendall and Associates, a telecommunications-focused consulting firm. He also managed regional and international distribution for Domino’s Pizza during the company’s growth in the late 1980s. Previously he was an audit supervisor for Peat, Marwick, Mitchell & Company. Mr. Demski also serves on the Board of Directors of Axonics Modulation Technologies, Inc. (NASDAQ: AXNX). Mr. Demski received a B.S. in Business Administration from the University of Michigan and an M.B.A. from Stanford Graduate School of Business.

What is David M. Demski's net worth?: The estimated net worth of David M. Demski is at least $23.83 million as of August 21st, 2024. Mr. Demski owns 288,441 shares of Globus Medical stock worth more than $23,833,880 as of December 21st. This net worth evaluation does not reflect any other investments that Mr. Demski may own. Learn More about David M. Demski's net worth.
How do I contact David M. Demski?: The corporate mailing address for Mr. Demski and other Globus Medical executives is 2560 GENERAL ARMISTEAD AVENUE, AUDUBON PA, 19403. Globus Medical can also be reached via phone at (610) 930-1800 and via email at [email protected]. Learn More on David M. Demski's contact information.
Has David M. Demski been buying or selling shares of Globus Medical?: David M. Demski has not been actively trading shares of Globus Medical during the last quarter. Most recently, David M. Demski sold 144,263 shares of the business's stock in a transaction on Monday, April 26th. The shares were sold at an average price of $71.50, for a transaction totalling $10,314,804.50. Following the completion of the sale, the chief executive officer now directly owns 21,875 shares of the company's stock, valued at $1,564,062.50. Learn More on David M. Demski's trading history.
Who are Globus Medical's active insiders?: Globus Medical's insider roster includes David Davidar (Director), David Demski (CEO), Robert Douglas (Director), Kelly Huller (SVP), Dan Lemaitre (Director), Leslie Norwalk (Director), Keith Pfeil (CFO), Ann Rhoads (Director), Daniel Scavilla (EVP), and James Tobin (Director). Learn More on Globus Medical's active insiders.
Are insiders buying or selling shares of Globus Medical?: During the last year, insiders at the medical device company sold shares 9 times. They sold a total of 207,390 shares worth more than $14,740,737.10. The most recent insider tranaction occured on December, 2nd when SVP Kelly Huller sold 2,500 shares worth more than $217,500.00. Insiders at Globus Medical own 18.5% of the company. Learn More about insider trades at Globus Medical.
Information on this page was last updated on 12/2/2024.

David M. Demski Insider Trading History at Globus Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/26/2021	Sell	144,263	$71.50	$10,314,804.50	21,875
4/23/2021	Sell	121,259	$71.59	$8,680,931.81	21,875
12/16/2020	Sell	52,356	$64.20	$3,361,255.20	151,980
4/19/2018	Sell	149,109	$51.00	$7,604,559.00	192,018
4/13/2018	Sell	50,891	$51.00	$2,595,441.00	152,701
11/1/2013	Sell	112,677	$18.59	$2,094,665.43
8/8/2012	Sell	98,957	$11.16	$1,104,360.12

David M. Demski Buying and Selling Activity at Globus Medical

Globus Medical Company Overview

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Today's Range

Now: $82.63

$81.27

$83.27

50 Day Range

MA: $80.02

$71.15

$85.61

2 Week Range

Now: $82.63

$49.33

$87.22

Volume

2,828,484 shs

Average Volume

1,002,211 shs

Market Capitalization

$11.25 billion

P/E Ratio

123.33

Dividend Yield

N/A

Beta

1.19

Did You See Trump’s Bombshell Exec. Order 001?

From Banyan Hill Publishing | Ad

Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."

I put all the details together for you here — but please hurry.